Ozempic maker Novo Nordisk slows
Photo: Ida Marie Odgaard/Ritzau

Ozempic maker Novo Nordisk slows Danish growth

A downturn in the pharmaceutical sector, dominated by Ozempic maker Novo Nordisk, contributed to the Danish economy growing by just 0.2 percent in the fourth quarter of last year, preliminary GDP figures show.

Advertisement

Excluding the country's large pharmaceutical sector, growth in the quarter would have been 1.2 percent.

Denmark's pharmaceutical sector saw a decline of 1.1 percent in the fourth quarter. Last fall, Denmark's central bank lowered its growth forecast for Denmark's economy due to lower expectations for the pharmaceutical industry.

In previous quarters, the pharmaceutical sector has contributed to a boost in GDP. For the full year 2025, the Danish economy grew by 2.9 percent.

AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All